Cenerimod's Development Targets Severe SLE Disease Activity
Novel S1P1 receptor modulator cenerimod shows impact on disease activity in lupus, with more pronounced benefits in those with more severe disease.
Source: medscape.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Sandra Navarra. Real-time updates on events, politics, business and more.